首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis
【24h】

Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis

机译:受体相互作用蛋白激酶介导视网膜脱离诱导的感光细胞坏死并补偿细胞凋亡的抑制

获取原文
获取原文并翻译 | 示例
       

摘要

Apoptosis has been shown to be a significant form of cell loss in many diseases. Detachment of photoreceptors from the retinal pigment epithelium, as seen in various retinal disorders, causes photoreceptor loss and subsequent vision decline. Although caspase-dependent apoptotic pathways are activated after retinal detachment, caspase inhibition by the pan-caspase inhibitor Z-VAD fails to prevent photoreceptor death; thus, we investigated other pathways leading to cell loss. Here, we show that receptor interacting protein (RIP) kinase-mediated necrosis is a significant mode of photoreceptor cell loss in an experimental model of retinal detachment and when caspases are inhibited, RIP-mediated necrosis becomes the predominant form of death. RIP3 expression, a key activator of RIP1 kinase, increased more than 10-fold after retinal detachment. Morphological assessment of detached retinas treated with Z-VAD showed decreased apoptosis but significantly increased necrotic photoreceptor death. RIP1 kinase inhibitor necrostatin-1 or Rip3 deficiency substantially prevented those necrotic changes and reduced oxidative stress and mitochondrial release of apoptosis-inducing factor. Thus, RIP kinase-mediated programmed necrosis is a redundant mechanism of photoreceptor death in addition to apoptosis, and simultaneous inhibition of RIP kinases and caspases is essential for effective neuroprotection and may be a novel therapeutic strategy for treatment of retinal disorders.
机译:在许多疾病中,凋亡已被证明是细胞损失的重要形式。如在各种视网膜疾病中所见,从视网膜色素上皮上分离感光细胞会导致感光细胞丧失和随后的视力下降。尽管视网膜脱离后激活了依赖半胱天冬酶的凋亡途径,但泛半胱天冬酶抑制剂Z-VAD对半胱天冬酶的抑制不能阻止光感受器的死亡。因此,我们研究了导致细胞丢失的其他途径。在这里,我们表明,在视网膜脱离的实验模型中,受体相互作用蛋白(RIP)激酶介导的坏死是光感受器细胞丢失的一种重要模式,当胱天蛋白酶被抑制时,RIP介导的坏死成为死亡的主要形式。视网膜脱离后,RIP1激酶的关键激活剂RIP3表达增加了10倍以上。 Z-VAD处理的视网膜脱离的形态学评估显示凋亡减少,但坏死性光感受器死亡显着增加。 RIP1激酶抑制剂necrostatin-1或Rip3缺乏基本上可以阻止那些坏死的改变,并减少氧化应激和凋亡诱导因子的线粒体释放。因此,RIP激酶介导的程序性坏死是除细胞凋亡外的光感受器死亡的冗余机制,同时抑制RIP激酶和胱天蛋白酶对有效的神经保护至关重要,并且可能是治疗视网膜疾病的新治疗策略。

著录项

  • 来源
  • 作者单位

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

    TetraLogic Pharmaceuticals, Malvern, PA 1935S;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114,Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114,Department of Ophthalmology, Harvard Medical School,Boston, MA 02114;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    degenerations; necroptosis;

    机译:变性;坏死;
  • 入库时间 2022-08-18 00:41:31

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号